Detection of prostate cancer with MR spectroscopic imaging: An expanded paradigm incorporating polyamines

Radiology

Volumn 245, Issue 2, 2007, Pages 499-506

  Shukla Dave, Amita ^a   Hricak, Hedvig ^a   Moskowitz, Chaya ^a   Ishill, Nicole ^a   Akin, Oguz ^a   Kuroiwa, Kentaro ^a,b   Spector, Jessica ^a   Kumar, Mahesh ^a   Reuter, Victor E ^a   Koutcher, Jason A ^a   Zakian, Kristen L ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CITRIC ACID; CREATINE; POLYAMINE;

ADULT; AGED; AIRWAY CONDUCTANCE; ARTICLE; CALCULATION; CHOLINE PLUS CREATINE TO CITRATE RATIO; CLASSIFICATION; CLINICAL ARTICLE; CORRELATION ANALYSIS; DATA ANALYSIS SOFTWARE; DECISION MAKING; DEVICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIGITAL IMAGING AND COMMUNICATIONS IN MEDICINE; HISTOPATHOLOGY; HUMAN; MALE; MATHEMATICAL ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; PROTON NUCLEAR MAGNETIC RESONANCE; RATING SCALE; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS; STANDARD; TUMOR BIOPSY; VALIDATION PROCESS;

ADULT; AGED; ALGORITHMS; DIAGNOSIS, COMPUTER-ASSISTED; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; POLYAMINES; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 35349029795     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2452062201     Document Type: Article

References (38)

1. Scheidler J, Hricak H, Vigneron DB, et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging - clinicopathologic study. Radiology 1999;213:473-480.
2. Jung JA, Coakley FV, Vigneron DB, et al. Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system. Radiology 2004;233:701-708.
3. 3) spatial resolution. Radiology 1996;198:795-805.
4. Males RG, Vigneron DB, Star-Lack J, et al. Clinical application of BASING and spectral-spatial water and lipid suppression pulses for prostate cancer staging and localization by in vivo 3D 1H magnetic resonance spectroscopic imaging. Magn Reson Med 2000;43:17-22.
5. Cohen RJ, Fujiwara K, Holland JW, McNeal JE. Polyamines in prostatic epithelial cells and adenocarcinoma: the effects of androgen blockade. Prostate 2001;49:278-284.
6. Gerner EW, Meyskens FL Jr. Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer 2004;4:781-792.
7. Medina MA, Correa-Fiz F, Rodriguez-Caso C, Sanchez-Jimenez F. A comprehensive view of polyamine and histamine metabolism to the light of new technologies. J Cell Mol Med 2005;9:854-864.
8. Schipper RG, Romijn JC, Cuijpers VM, Verhofstad AA. Polyamines and prostatic cancer. Biochem Soc Trans 2003;31:375-380.
9. Takyi EE, Fuller DJ, Donaldson LJ, Thomas GH. Deoxyribonucleic acid and polyamine synthesis in rat ventral prostrate: effects of age of the intact rat and androgen stimulation of the castrated rat with testosterone, 5 alpha-dihydrotestosterone and 5 alpha-androstane-3 beta, 17 beta-diol. Biochem J 1977;162:87-97.
10. Wallace HM, Fraser AV, Hughes A. A perspective of polyamine metabolism. Biochem J 2003;376(pt 1):1-14.
11. Cheng LL, Wu C, Smith MR, Gonzalez RG. Non-destructive quantitation of spermine in human prostate tissue samples using HRMAS 1H NMR spectroscopy at 9.4 T. FEBS Lett 2001;494:112-116.
12. Kurhanewicz J, Dahiya R, Macdonald JM, Chang LH, James TL, Narayan P. Citrate alterations in primary and metastatic human prostatic adenocarcinomas: 1H magnetic resonance spectroscopy and biochemical study. Magn Reson Med 1993;29:149-157.
13. Swanson MG, Vigneron DB, Tabatabai ZL, et al. Proton HR-MAS spectroscopy and quantitative pathologic analysis of MRI/3D-MRSI-targeted postsurgical prostate tissues. Magn Reson Med 2003;50:944-954.
14. van der Graaf M, Schipper RG, Oosterhof GO, Schalken JA, Verhofstad AA, Heerschap A. Proton MR spectroscopy of prostatic tissue focused on the detection of spermine, a possible biomarker of malignant behavior in prostate cancer. MAGMA 2000;10:153-159.
15. Hricak H, Wang L, Wei DC, et al. The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy. Cancer 2004;100:2655-2663.
16. Mullerad M, Hricak H, Kuroiwa K, et al. Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. J Urol 2005;174:2158-2163.
17. Wang L, Mullerad M, Chen HN, et al. Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension. Radiology 2004;232:133-139.
18. Yu KK, Scheidler J, Hricak H, et al. Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology 1999;213:481-488.
19. Bottomley P. Selective volume method for performing localized NMR spectroscopy. U.S. patent 4,480,228. 1984.
20. Schricker AA, Pauly JM, Kurhanewicz J, Swanson MG, Vigneron DB. Dualband spectral-spatial RF pulses for prostate MR spectroscopic imaging. Magn Reson Med 2001;46:1079-1087.
21. Pels P, Ozturk-Isik E, Swanson MG, et al. Quantification of prostate MRSI data by model-based time domain fitting and frequency domain analysis. NMR Biomed 2006;19:188-197.
22. Aihara M, Wheeler TM, Ohori M, Scardino PT. Heterogeneity of prostate cancer in radical prostatectomy specimens. Urology 1994;43:60-66.
23. Rao JN, Scott AJ. The analysis of categorical data from complex sample surveys: chi-squared tests for goodness of fit and independence in two-way tables. J Am Stat Assoc 1981;76:221-230.
24. Obuchowski NA. Nonparametric analysis of clustered ROC curve data. Biometrics 1997;53:567-578.
25. Breiman L, Friedman J, Olshen R, Stone C. Classification and regression trees. Belmont, Calif: Wadsworth, 1984.
26. Chambers JM, Hastie TJ. Statistical models. London, England: Chapman & Hall, 1996.
27. Harrell FE. Regression modeling strategies. New York, NY: Springer, 2001.
28. Myers RH. Classical and modern regression with applications. Boston, Mass: PWS-Kent, 1990.
29. Beam CA, Wieand HS. A statistical method for the comparison of a discrete diagnostic test with several continuous diagnostic tests. Biometrics 1991;47:907-919.
30. Zakian KL, Sircar K, Hricak H, et al. Correlation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology 2005;234:804-814.
31. Swanson MG, Vigneron DB, Tran TK, Sailasuta N, Hurd RE, Kurhanewicz J. Single-voxel oversampled J-resolved spectroscopy of in vivo human prostate tissue. Magn Reson Med 2001;45:973-980.
32. Casciani E, Polettini E, Bertini L, et al. Prostate cancer: evaluation with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiol Med (Torino) 2004;108:530-541.
33. Futterer JJ, Heijmink SW, Scheenen TW, et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 2006;241:449-458.
34. Prando A, Kurhanewicz J, Borges AP, Oliveira EM Jr, Figueiredo E. Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience. Radiology 2005;236:903-910.
35. Squillaci E, Manenti G, Mancino S, et al. MR spectroscopy of prostate cancer: initial clinical experience. J Exp Clin Cancer Res 2005;24:523-530.
36. Chen AP, Cunningham CH, Kurhanewicz J, et al. High-resolution 3D MR spectroscopic imaging of the prostate at 3 T with the MLEV-PRESS sequence. Magn Reson Imaging 2006;24:825-832.
37. Cunningham CH, Vigneron DB, Marjanska M, et al. Sequence design for magnetic resonance spectroscopic imaging of prostate cancer at 3 T. Magn Reson Med 2005;53:1033-1039.
38. Scheenen TW, Gambarota G, Weiland E, et al. Optimal timing for in vivo 1H-MR spectroscopic imaging of the human prostate at 3T. Magn Reson Med 2005;53:1268-1274.